121 related articles for article (PubMed ID: 17493308)
21. Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients.
Delong LK; Culler SD; Saini SS; Beck LA; Chen SC
Arch Dermatol; 2008 Jan; 144(1):35-9. PubMed ID: 18209166
[TBL] [Abstract][Full Text] [Related]
22. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.
Shih YC; Xu Y; Cormier JN; Giordano S; Ridner SH; Buchholz TA; Perkins GH; Elting LS
J Clin Oncol; 2009 Apr; 27(12):2007-14. PubMed ID: 19289624
[TBL] [Abstract][Full Text] [Related]
23. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids.
Dembek CJ; Pelletier EM; Isaacson KB; Spies JB
J Vasc Interv Radiol; 2007 Oct; 18(10):1207-13. PubMed ID: 17911509
[TBL] [Abstract][Full Text] [Related]
24. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
Krummenauer F; Günther KP; Witzlebf WC
Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
[TBL] [Abstract][Full Text] [Related]
25. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the costs and resource use associated with adjuvant chemotherapy for breast cancer in France.
Laas E; Vataire AL; Aballea S; Valentine W; Gligorov J; Chereau E; Rouzier R
J Med Econ; 2012; 15(6):1167-75. PubMed ID: 22853442
[TBL] [Abstract][Full Text] [Related]
27. Cost of breast cancer in Sweden in 2002.
Lidgren M; Wilking N; Jönsson B
Eur J Health Econ; 2007 Mar; 8(1):5-15. PubMed ID: 17216424
[TBL] [Abstract][Full Text] [Related]
28. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
29. A health economic evaluation of follow-up after breast cancer surgery: results of an rct study.
Koinberg I; Engholm GB; Genell A; Holmberg L
Acta Oncol; 2009; 48(1):99-104. PubMed ID: 18766474
[TBL] [Abstract][Full Text] [Related]
30. Resource use and cost of diagnostic workup of women with suspected breast cancer.
Lee DW; Stang PE; Goldberg GA; Haberman M
Breast J; 2009; 15(1):85-92. PubMed ID: 19120378
[TBL] [Abstract][Full Text] [Related]
31. Health care costs for treatment of disseminated breast cancer.
Dahlberg L; Lundkvist J; Lindman H
Eur J Cancer; 2009 Jul; 45(11):1987-91. PubMed ID: 19398326
[TBL] [Abstract][Full Text] [Related]
32. Estimates of the lifetime direct costs of treatment for metastatic breast cancer.
Berkowitz N; Gupta S; Silberman G
Value Health; 2000; 3(1):23-30. PubMed ID: 16464178
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of venous leg ulcers can be better and cheaper. Annual costs calculation based on an inquiry study].
Tennvall GR; Andersson K; Bjellerup M; Hjelmgren J; Oien R
Lakartidningen; 2004 Apr; 101(17):1506-10, 1512-3. PubMed ID: 15150953
[TBL] [Abstract][Full Text] [Related]
34. The burden of illness associated with renal cell carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
[TBL] [Abstract][Full Text] [Related]
35. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
36. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
37. Glaucoma in the United States and europe: predicting costs and surgical rates based upon stage of disease.
Lee PP; Kelly SP; Mills RP; Traverso CE; Walt JG; Doyle JJ; Katz LM; Siegartel LR;
J Glaucoma; 2007 Aug; 16(5):471-8. PubMed ID: 17700290
[TBL] [Abstract][Full Text] [Related]
38. Participation, resource mobilization and financial incentives in community-based health promotion: an economic evaluation perspective from Sweden.
Johansson PM; Eriksson LS; Sadigh S; Rehnberg C; Tillgren PE
Health Promot Int; 2009 Jun; 24(2):177-84. PubMed ID: 19321496
[TBL] [Abstract][Full Text] [Related]
39. Influence on the health of the partner affected by tumor disease in the wife or husband based on a population-based register study of cancer in Sweden.
Sjövall K; Attner B; Lithman T; Noreen D; Gunnars B; Thomé B; Olsson H
J Clin Oncol; 2009 Oct; 27(28):4781-6. PubMed ID: 19720912
[TBL] [Abstract][Full Text] [Related]
40. [Cost of treatment and follow up of breast cancer: a retrospective assessment in a comprehensive cancer centre].
Lilliu H; Stevens D; Brun C; Morel J; Pen CL; Bonastre J; Bachelot F; Davesne C; Gentile A; Hirlimann E; Sabourin JC; Berlie J; Rouëssé J
Bull Cancer; 2002 Jun; 89(6):635-42. PubMed ID: 12135864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
